Canada markets closed

Navidea Biopharmaceuticals, Inc. (NAVB)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0381+0.0005 (+1.33%)
At close: 01:08PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPSN/A-0.11N/AN/A
Revenue EstimateCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts0011
Avg. EstimateN/AN/A21.66M44.54M
Low EstimateN/AN/A21.66M44.54M
High EstimateN/AN/A21.66M44.54M
Year Ago SalesN/AN/AN/A21.66M
Sales Growth (year/est)N/AN/AN/A105.60%
Earnings HistoryInvalid Date2021-03-302021-06-292021-09-29
EPS Est.N/A-0.08-0.08-0.11
EPS ActualN/A-0.11-0.09-0.08
DifferenceN/A-0.03-0.010.03
Surprise %N/A-37.50%-12.50%27.30%
EPS TrendCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Current Estimate0000
7 Days Ago00-0.010.57
30 Days Ago00-0.010.57
60 Days Ago00-0.010.57
90 Days Ago00-0.010.57
EPS RevisionsCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNAVBIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current YearN/AN/AN/AN/A
Next YearN/AN/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A